The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
55 jobs Number of planned job losses
Announcement Date
30 July 2008
Employment effect (start)
Foreseen end date
Description
GlaxoSmithKline, a company that operates in the pharmaceutical sector, has announced that it is to cut 55 jobs at its plant in Montrose, Angus. 300 people are currently permanently employed at the site, and another 70 temporary staff will see their roles phased out by the end of the year. The company is cutting the jobs as demand for products made at the factory has not been as high as predicted. As of 3 August 2008 it is not known when workers will be made redundant.
Sources
30 July 2008: BBC News
Citation
Eurofound (2008), Glaxo Smith Kline, Internal restructuring in United Kingdom, factsheet number 66940, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66940.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
